Global Short Bowel Syndrome Drugs Sales Market Report 2018 by Manufacturer, Region, Type and Application

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Short Bowel Syndrome Drugs Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Oral Route Market Performance (Volume)
  • 2.1.2 Parental Route Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Oral Route Market Performance (Value)
  • 2.1.2 Parental Route Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Hospital Pharmacies Market Performance (Volume)
  • 3.1.2 Retail Pharmacies Market Performance (Volume)
  • 3.1.3 Online Pharmacies Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Emmaus Medical
  • 4.1.1 Emmaus Medical Profiles
  • 4.1.2 Emmaus Medical Product Information
  • 4.1.3 Emmaus Medical Short Bowel Syndrome Drugs Business Performance
  • 4.1.4 Emmaus Medical Short Bowel Syndrome Drugs Business Development and Market Status
• 4.2 Merck
  • 4.2.1 Merck Profiles
  • 4.2.2 Merck Product Information
  • 4.2.3 Merck Short Bowel Syndrome Drugs Business Performance
  • 4.2.4 Merck Short Bowel Syndrome Drugs Business Development and Market Status
• 4.3 Shire
  • 4.3.1 Shire Profiles
  • 4.3.2 Shire Product Information
  • 4.3.3 Shire Short Bowel Syndrome Drugs Business Performance
  • 4.3.4 Shire Short Bowel Syndrome Drugs Business Development and Market Status
• 4.4 Ardelyx
  • 4.4.1 Ardelyx Profiles
  • 4.4.2 Ardelyx Product Information
  • 4.4.3 Ardelyx Short Bowel Syndrome Drugs Business Performance
  • 4.4.4 Ardelyx Short Bowel Syndrome Drugs Business Development and Market Status
• 4.5 Naia Pharmaceuticals
  • 4.5.1 Naia Pharmaceuticals Profiles
  • 4.5.2 Naia Pharmaceuticals Product Information
  • 4.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Business Performance
  • 4.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Business Development and Market Status
• 4.6 Nutrinia
  • 4.6.1 Nutrinia Profiles
  • 4.6.2 Nutrinia Product Information
  • 4.6.3 Nutrinia Short Bowel Syndrome Drugs Business Performance
  • 4.6.4 Nutrinia Short Bowel Syndrome Drugs Business Development and Market Status
• 4.7 OxThera
  • 4.7.1 OxThera Profiles
  • 4.7.2 OxThera Product Information
  • 4.7.3 OxThera Short Bowel Syndrome Drugs Business Performance
  • 4.7.4 OxThera Short Bowel Syndrome Drugs Business Development and Market Status
• 4.8 GLyPharma Therapeutic
  • 4.8.1 GLyPharma Therapeutic Profiles
  • 4.8.2 GLyPharma Therapeutic Product Information
  • 4.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Business Performance
  • 4.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Business Development and Market Status
• 4.9 Sancilio Pharmaceuticals
  • 4.9.1 Sancilio Pharmaceuticals Profiles
  • 4.9.2 Sancilio Pharmaceuticals Product Information
  • 4.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Business Performance
  • 4.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Business Development and Market Status
• 4.10 Zealand Pharma
  • 4.10.1 Zealand Pharma Profiles
  • 4.10.2 Zealand Pharma Product Information
  • 4.10.3 Zealand Pharma Short Bowel Syndrome Drugs Business Performance
  • 4.10.4 Zealand Pharma Short Bowel Syndrome Drugs Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Global Short Bowel Syndrome Drugs Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Short Bowel Syndrome Drugs Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Short Bowel Syndrome Drugs Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Short Bowel Syndrome Drugs Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 China Market Performance for Manufacturers
  • 6.1.1 China Short Bowel Syndrome Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 China Short Bowel Syndrome Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 China Short Bowel Syndrome Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 China Short Bowel Syndrome Drugs Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 USA Market Performance for Manufacturers
  • 6.2.1 USA Short Bowel Syndrome Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 USA Short Bowel Syndrome Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 USA Short Bowel Syndrome Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 USA Short Bowel Syndrome Drugs Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 Europe Market Performance for Manufacturers
  • 6.3.1 Europe Short Bowel Syndrome Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 Europe Short Bowel Syndrome Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 Europe Short Bowel Syndrome Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 Europe Short Bowel Syndrome Drugs Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Japan Market Performance for Manufacturers
  • 6.4.1 Japan Short Bowel Syndrome Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Japan Short Bowel Syndrome Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Japan Short Bowel Syndrome Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Japan Short Bowel Syndrome Drugs Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Korea Market Performance for Manufacturers
  • 6.5.1 Korea Short Bowel Syndrome Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Korea Short Bowel Syndrome Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Korea Short Bowel Syndrome Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Korea Short Bowel Syndrome Drugs Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 India Market Performance for Manufacturers
  • 6.6.1 India Short Bowel Syndrome Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 India Short Bowel Syndrome Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 India Short Bowel Syndrome Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 India Short Bowel Syndrome Drugs Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Southeast Asia Market Performance for Manufacturers
  • 6.7.1 Southeast Asia Short Bowel Syndrome Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Southeast Asia Short Bowel Syndrome Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Southeast Asia Short Bowel Syndrome Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Southeast Asia Short Bowel Syndrome Drugs Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 South America Market Performance for Manufacturers
  • 6.8.1 South America Short Bowel Syndrome Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 South America Short Bowel Syndrome Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 South America Short Bowel Syndrome Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 South America Short Bowel Syndrome Drugs Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Global Short Bowel Syndrome Drugs Market Performance (Sales Point)

• 7.1 Global Short Bowel Syndrome Drugs Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Global Short Bowel Syndrome Drugs Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Global Short Bowel Syndrome Drugs Price (USD/Unit) by Regions 2013-2018
• 7.4 Global Short Bowel Syndrome Drugs Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Global Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 China Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 USA Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 Europe Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Japan Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Korea Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 India Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Southeast Asia Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Southeast Asia Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Hospital Pharmacies Industry
• 11.2 Retail Pharmacies Industry
• 11.3 Online Pharmacies Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Global Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Global Short Bowel Syndrome Drugs Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 China Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 USA Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 Europe Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Japan Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Korea Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 India Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Southeast Asia Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 South America Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Oral Route Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Parental Route Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Hospital Pharmacies Sales and and Growth Rate 2019-2024
  • 12.4.3 Retail Pharmacies Sales and and Growth Rate 2019-2024
  • 12.4.4 Online Pharmacies Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Global Short Bowel Syndrome Drugs Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Global Short Bowel Syndrome Drugs Gross Profit Trend 2019-2024

13 Conclusion